β¨ Medicines Consent Notices
7 AUGUST
NEW ZEALAND GAZETTE
2475
Note: This consent is valid for six months from the date of publication of this notice.
Dated this 5th day of August 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go5129
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Kabiven Peripheral
Glucose Component:
Active Ingredient: Glucose monohydrate 12.1% equivalent to 11% glucose anhydrous
Dosage Form: Solution for injection
Vamin 18 Novum Component:
Active Ingredients: Alanine 1.6%
Arginine 1.13%
Aspartic acid 0.34%
Calcium chloride dihydrate 0.074%
Glutamic acid 0.56%
Glycine 0.79%
Histidine 0.68%
Isoleucine 0.56%
Leucine 0.79%
Lysine hydrochloride 0.9%
Magnesium sulphate 0.16%
Methionine 0.56%
Phenylalanine 0.79%
Potassium chloride 0.597%
Proline 0.68%
Serine 0.45%
Sodium acetate trihydrate 0.49%
Sodium glycerophosphate 0.54%
Threonine 0.56%
Tryptophan 0.19%
Tyrosine 0.023%
Valine 0.73%
Dosage Form: Solution for injection
Intralipid Component:
Active Ingredient: Soya oil 20%
Dosage Form: Emulsion for injection
New Zealand Sponsor: Fresenius Medical Care Australia Pty Limited
Manufacturer: Fresenius Kabi AB, Uppsala, Sweden
Product: Kabiven
Glucose Component:
Active Ingredient: Glucose monohydrate 20.9% equivalent to 19% glucose anhydrous
Dosage Form: Solution for injection
Vamin 18 Novum Component:
Active Ingredients: Alanine 1.6%
Arginine 1.13%
Aspartic acid 0.34%
Calcium chloride dihydrate 0.074%
Glutamic acid 0.56%
Glycine 0.79%
Histidine 0.68%
Isoleucine 0.56%
Leucine 0.79%
Lysine hydrochloride 0.9%
Magnesium sulphate 0.16%
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 94
Gazette.govt.nz —
NZ Gazette 2003, No 94
β¨ LLM interpretation of page content
π₯
Provisional Consent for Diabex
(continued from previous page)
π₯ Health & Social Welfare5 August 2003
Medicines Act, Provisional Consent, Diabex, Metformin hydrochloride, Pacific Pharmaceuticals, Lipha SA
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act, Consent, Kabiven Peripheral, Kabiven, Fresenius Medical Care, Fresenius Kabi AB